Company Filing History:
Years Active: 2022-2025
Title: Innovations in Ovarian Cancer Detection by Karina Martin
Introduction
Karina Martin is an accomplished inventor based in Largs North, Australia. She has made significant contributions to the field of medical research, particularly in the detection of ovarian cancer. With two patents to her name, her work focuses on identifying biological markers that can aid in early diagnosis and treatment of this disease.
Latest Patents
Karina's latest patents revolve around the identification of autoantibody biomarkers of ovarian cancer. These patents detail the discovery of cancer-associated autoantibodies to various proteins, including ANXA1, ARP3, SAHH, SERPH, ARAP1, OTUB1, ATP1A1, UBA1, and CFAH. These autoantibodies have been identified in subjects with early-stage ovarian cancer and can be utilized for multiple purposes. They include methods for detecting ovarian cancer, screening for early-stage ovarian cancer, and assessing treatment response, disease progression, and recurrence. Furthermore, these autoantibodies serve as prognostic markers for ovarian cancer development.
Career Highlights
Karina Martin is affiliated with Adelaide Research & Innovation Pty Ltd, where she continues her research and development efforts. Her work has garnered attention for its potential impact on improving ovarian cancer detection and treatment outcomes.
Collaborations
Some of her notable coworkers include Peter Hoffmann and Martin Oehler, who have collaborated with her on various research projects.
Conclusion
Karina Martin's innovative work in identifying autoantibody biomarkers for ovarian cancer represents a significant advancement in medical research. Her contributions have the potential to enhance early detection and improve patient outcomes in the fight against ovarian cancer.